Biomolecular Display Technology: A New Tool for Drug Discovery

Animal Biotechnology: Models in Discovery and Translation

Volumn , Issue , 2013, Pages 369-384

  Biyani, Madhu ^a,b   Nishigaki, Koichi ^b   Biyani, Manish ^a,c  

^a Biyani Group of Colleges   (India)

^b SAITAMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Directed Molecular Evolution; Display Technology; Drug Discovery; In Vitro Selection; Peptide Aptamer

Indexed keywords

EID: 84902051285     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-416002-6.00020-1     Document Type: Chapter

References (45)

1. Ashraf S.S., Anderson E., Duke K., Hamilton P.T., Fredericks Z. The Journal of Peptide Research 2003, 61:263-273.
2. Baggio R., Burgstaller P., Hale S.P., Putney A.R., Lane M., Lipovsek D., Wright M.C., Roberts R.W., Liu R., Szostak J.W., Wagner R.W. Identification of epitope-like consensus motifs using mRNA display. Journal of Molecular Recognition 2002, 15:126-134.
3. Bertschinger J., Grabulovski D., Neri D. Selection of single domain binding proteins by covalent DNA display. Protein Engineering, Design & Selection 2007, 20:57-68.
4. Biyani M., Futakami M., Kitamura K., Kawakubo T., Suzuki M., Yamamoto K., Nishigaki K. In vitro selection of cathepsin E-activity enhancing peptide aptamers at neutral pH. International Journal of Peptides 2011, 834525.
5. Boder E.T., Wittrup K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nature Biotechnology 1997, 15:553-557.
6. Crawford M., Woodman R. Ko Ferrigno P. Peptide aptamers: tools for biology and drug discovery. Briefings in Functional Genomics Proteomics 2003, 2:72-79.
7. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
8. Francisco J.A., Earhart C.F., Georgiou G. Transport and anchoring of beta-lactamase to the external surface of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:2713-2717.
9. Franklin M.C., Kadkhodayan S., Ackerly H., Alexandru D., Distefano M.D., Elliott L.O., Flygare J.A., Mausisa G., Okawa D.C., Ong D., Vucic D., Deshayes K., Fairbrother W.J. Biochemistry 2003, 42:8223-8231.
10. George R.A., Smith T.D., Callaghan S., Hardman L., Pierides C., Horaitis O., Wouters M.A., Cotton R.G. General mutation databases: analysis and review. Journal of Medical Genetics 2008, 45:65-70.
11. Gersuk G.M., Corey M.J., Corey E., Stray J.E., Kawasaki G.H., Vessella R.L. High-affinity peptide ligands to prostate-specific antigen identified by polysome selection. Biochemical and Biophysical Research Communications 1997, 232:578-582.
12. Gold L., Tuerk C. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
13. Gragoudas E.S., Adamis A.P., Cunningham E.T., Feinsod M., Guyer D.R. Pegaptanib for neovascular age-related macular degeneration. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. The New England Journal of Medicine 2004, 351:2805-2816.
14. Hetian L., Ping A., Shumei S., Xiaoying L., Luowen H., Jian W., Lin M., Meisheng L., Junshan Y., Chengchao S. The Journal of Biological Chemistry 2002, 277:43137-43142.
15. Huang L., Sexton D.J., Skogerson K., Devlin M., Smith R., Sanyal I., Parry T., Kent R., Enright J., Wu Q.L., Conley G., DeOliveira D., Morganelli L., Ducar M., Wescott C.R., Ladner R.C. Novel peptide inhibitors of angiotensin-converting enzyme 2. The Journal of Biological Chemistry 2003, 278:15532-15540.
16. Kawakubo T., Okamoto K., Iwata J., Shin M., Okamoto Y., Yasukochi A., Nakayama K.I., Kadowaki T., Tsukuba T., Yamamoto K. Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface. Cancer Research 2007, 67:10869-10878.
17. Kitamura K., Kinoshita Y., Narasaki S., Nemoto N., Husimi Y., Nishigaki K. Construction of block-shuffled libraries of DNA for evolutionary protein engineering: Y-ligation-based block shuffling. Protein Engineering 2002, 15:843-853.
18. Kitamura K., Yoshida C., Kinoshita Y., Kadowaki T., Takahashi Y., Tayama T., Kawakubo T., Naimuddin M., Salimullah M., Nemoto N., Hanada K., Husimi Y., Yamamoto K., Nishigaki K. Development of systemic in vitro evolution and its application to generation of peptide-aptamer-based inhibitors of cathepsin E. Journal of Molecular Biology 2009, 387:1186-1198.
19. Kitamura K., Biyani M., Futakami M., Suzuki M., Kawakubo T., Yamamoto K., Nishigaki K. Peptide aptamer-based ELISA-like system for detection of cathepsin E in tissues and plasma. Journal of Molecular Biomarkers Diagnostic 2011, 2:104. (, ). http://dx.doi.org/10.4172/2155-9929.1000104.
20. Kitamura K., Komatsu M., Biyani M., Futakami M., Kawakubo T., Yamamoto K., Nishigaki K. Proven in vitro evolution of protease cathepsin E inhibitors and activators by a paired peptides method. Journal of Peptide Science 2012, 10.1002/psc.2453.
21. Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates?. Nature Reviews. Drug Discovery 2004, 3:711-715.
22. Lamla T., Erdmann V.A. Searching sequence space for high-affinity binding peptides using ribosome display. Journal of Molecular Biology 2003, 329:381-388.
23. Li M. Applications of display technology in protein analysis. Nature Biotechnology 2000, 18:1251-1256.
24. Litovchick A., Szostak J.W. Selection of cyclic peptide aptamers to HCV IRES RNA using mRNA display. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:15293-15298.
25. Mattheakis L.C., Bhatt R.R., Dower W.J. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:9022-9026.
26. Naimuddin M., Kitamura K., Kinoshita Y., Honda-Takahashi Y., Murakami M., Ito M., Yamamoto K., Hanada K., Husimi Y., Nishigaki K. Selection-by-function: efficient enrichment of cathepsin E inhibitors from a DNA library. Journal of Molecular Recognition 2007, 20:58-68.
27. Nemoto N., Miyamoto-Sato E., Husimi Y., Yanagawa H. In vitro virus: bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Letters 1997, 414:405-408.
28. Nouvion A.L., Thibaut J., Lohez O.D., Venet S., Colas P., Gillet G., Lalle P. Modulation of Nr-13 antideath activity by peptide aptamers. Oncogene 2007, 26:701-710.
29. Odegrip R., Coomber D., Eldridge B., Hederer R., Kuhlman P.A., et al. CIS display: In vitro selection of peptides from libraries of protein-DNA complexes. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2806-2810.
30. Pammolli F., Magazzini L., Riccaboni M. The productivity crisis in pharmaceutical R&D. Nature Reviews. Drug Discovery 2011, 10:428-438.
31. Roberts R.W., Szostak J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:12297-12302.
32. Russ A.P., Lampel S. The druggable genome: an update. Drug Discovery Today 2005, 10:1607-1610.
33. Sakharkar M.K., Sakharkar K.R., Pervaiz S. Druggability of human disease genes. The International Journal of Biochemistry & Cell Biology 2007, 39:1156-1164.
34. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228:1315-1317.
35. Smith G.P., Petrenko V.A. Phage display. Chemistry Reviews 1997, 97:391-410.
36. Tawfik D.S., Griffiths A.D. Man-made cell-like compartments for molecular evolution. Nature Biotechnology 1998, 16:652-656.
37. Vlieghe P., Lisowski V., Martinez J., Khrestchatisky M. Synthetic therapeutic peptides: science and market. Drug Discovery Today 2010, 15:40-56.
38. Wilson D.S., Keefe A.D., Szostak J.W. The use of mRNA display to select high-affinity protein-binding peptides. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:3750-3755.
39. Yamaguchi J., Naimuddin M., Biyani M., Sasaki T., Machida M., Kubo T., Funatsu T., Husimi Y., Nemoto N. cDNA display: a novel screening method for functional disulfide-rich peptides by solid-phase synthesis and stabilization of mRNA-protein fusions. Nucleic Acids Research 2009, 37. e108.
40. Douthwaite Julie A., Ronald H. Ribosome Display and Related Technologies: Methods and Protocols. Methods in Molecular Biology 2012, Vol. 805. Humana Press, Jackson.
41. Nakata T. Total synthesis of macrolides. Macrolide Antibiotics: Chemistry, Biology and Practice 2002, 220-232. Academic Press. S. Omura (Ed.).
42. Ng Rick Drug Discovery: Large Molecule Drugs. 'Drugs, from Discovery to Approval' 2009, 93-135. 2nd ed.
43. Phage Display in Biotechnology and Drug Discovery 2005, Boca Raton: CRC Press. S.S. Sidhu (Ed.).
44. The Process of New New Drug Discovery and Development 2006, Boca Raton: CRC Press. 2nd ed. C.G. Smith, J.T. O'Donnel (Eds.).
45. Spilker Bert Biotechnology. Guide to Drug Development, A Comprehensive Review and Assessment 2009, 119-131. Wolters Kluwer Press.